NASDAQ:RXST
RxSight, Inc. Stock News
$58.47
-1.05 (-1.76%)
At Close: May 31, 2024
ALISO VIEJO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. (Nasdaq: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cat
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
09:15pm, Wednesday, 08'th May 2024
ALISO VIEJO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following
RxSight, Inc. (RXST) Q1 2024 Earnings Call Transcript
10:06pm, Monday, 06'th May 2024
RxSight, Inc. (NASDAQ:RXST ) Q1 2024 Earnings Conference Call May 6, 2024 4:30 PM ET Company Participants Oliver Moravcevic – Vice President, Investor Relations Ron Kurtz – President and Chief Exe
RxSight, Inc. Reports First Quarter 2024 Financial Results
04:05pm, Monday, 06'th May 2024
ALISO VIEJO, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
04:05pm, Monday, 22'nd Apr 2024
ALISO VIEJO, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients follow
ALISO VIEJO, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients followi
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
04:05pm, Wednesday, 27'th Mar 2024
ALISO VIEJO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
07:05pm, Thursday, 29'th Feb 2024
ALISO VIEJO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following ca
RxSight, Inc. (RXST) Q4 2023 Earnings Call Transcript
11:44pm, Wednesday, 28'th Feb 2024
RxSight, Inc. (RXST) Q4 2023 Earnings Call Transcript
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
04:05pm, Wednesday, 28'th Feb 2024
ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
04:05pm, Wednesday, 14'th Feb 2024
ALISO VIEJO, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following
3 Stocks to Buy BEFORE They Become Household Names
03:16pm, Friday, 12'th Jan 2024
Steve Symington is a long-time contributor to The Motley Fool. Over the years, he's written more than 8,000 articles for the publication.
RxSight, Inc. (RXST) Just Overtook the 20-Day Moving Average
07:36pm, Tuesday, 09'th Jan 2024
RxSight, Inc. (RXST) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, RXST crossed above the 20-day moving average, suggesting
ALISO VIEJO, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
04:05pm, Wednesday, 27'th Dec 2023
ALISO VIEJO, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
